Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Cost of Revenue (2016 - 2022)

Skinvisible's Cost of Revenue history spans 13 years, with the latest figure at $3300.0 for Q3 2022.

  • For Q3 2022, Cost of Revenue changed N/A year-over-year to $3300.0; the TTM value through Jun 2023 reached $3300.0, up 118.83%, while the annual FY2022 figure was $4808.0, 45.7% up from the prior year.
  • Cost of Revenue for Q3 2022 was $3300.0 at Skinvisible, up from $1508.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $10352.0 in Q4 2019 and bottomed at -$118613.0 in Q2 2020.
  • The 5-year median for Cost of Revenue is $2404.0 (2021), against an average of -$5468.8.
  • The largest annual shift saw Cost of Revenue skyrocketed 4381.39% in 2019 before it plummeted 1904.55% in 2020.
  • A 5-year view of Cost of Revenue shows it stood at $231.0 in 2018, then surged by 4381.39% to $10352.0 in 2019, then crashed by 116.2% to -$1677.0 in 2020, then soared by 296.78% to $3300.0 in 2021, then changed by 0.0% to $3300.0 in 2022.
  • Per Business Quant, the three most recent readings for SKVI's Cost of Revenue are $3300.0 (Q3 2022), $1508.0 (Q1 2022), and $3300.0 (Q1 2021).